AFT Pharmaceuticals Ltd. (AU:AFP) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
AFT Pharmaceuticals has announced a collaboration with Massey Ventures and the Gillies McIndoe Research Institute to develop a new topical treatment for keloid and hypertrophic scars. The partnership aims to create the first effective non-invasive treatment option for these often disfiguring and painful scars. This collaboration builds upon their previous successful work on a treatment for strawberry birthmarks and further extends AFT’s R&D portfolio, emphasizing their commitment to international growth.
For further insights into AU:AFP stock, check out TipRanks’ Stock Analysis page.